Principal Financial Group Inc. Acquires 3,910 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Principal Financial Group Inc. increased its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 3.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 136,009 shares of the medical instruments supplier's stock after purchasing an additional 3,910 shares during the quarter. Principal Financial Group Inc. owned approximately 0.55% of ICU Medical worth $18,886,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of ICUI. Harvest Fund Management Co. Ltd bought a new stake in shares of ICU Medical in the 4th quarter valued at about $33,000. Quarry LP raised its holdings in shares of ICU Medical by 764.3% in the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after purchasing an additional 214 shares during the period. Murphy & Mullick Capital Management Corp bought a new stake in shares of ICU Medical in the 4th quarter valued at about $52,000. Russell Investments Group Ltd. raised its holdings in shares of ICU Medical by 88.8% in the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after purchasing an additional 300 shares during the period. Finally, GAMMA Investing LLC raised its holdings in shares of ICU Medical by 27.2% in the 1st quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock valued at $99,000 after purchasing an additional 153 shares during the period. 96.10% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ICUI. Wall Street Zen raised shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Sunday, May 18th. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Raymond James Financial lowered their price target on shares of ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a report on Friday, May 9th. Finally, KeyCorp lowered their price target on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $192.67.

Insider Activity

In other ICU Medical news, Director David C. Greenberg sold 1,942 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $143.66, for a total value of $278,987.72. Following the sale, the director owned 6,760 shares in the company, valued at $971,141.60. This trade represents a 22.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Elisha W. Finney sold 600 shares of the firm's stock in a transaction on Monday, May 19th. The shares were sold at an average price of $138.92, for a total transaction of $83,352.00. Following the transaction, the director directly owned 3,252 shares of the company's stock, valued at $451,767.84. The trade was a 15.58% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 36,097 shares of company stock worth $4,860,156. Insiders own 1.50% of the company's stock.

ICU Medical Stock Performance

Shares of NASDAQ:ICUI traded down $5.10 on Friday, reaching $132.16. 140,620 shares of the company's stock were exchanged, compared to its average volume of 259,275. The company has a fifty day moving average of $133.70 and a 200-day moving average of $145.00. ICU Medical, Inc. has a twelve month low of $117.92 and a twelve month high of $196.26. The company has a market capitalization of $3.25 billion, a price-to-earnings ratio of -34.51 and a beta of 0.87. The company has a current ratio of 2.59, a quick ratio of 1.52 and a debt-to-equity ratio of 0.75.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.23 by $0.49. ICU Medical had a negative net margin of 3.87% and a positive return on equity of 6.75%. The firm had revenue of $599.49 million for the quarter, compared to analyst estimates of $574.15 million. During the same quarter in the prior year, the business posted $0.96 EPS. The business's revenue was up 6.7% compared to the same quarter last year. On average, research analysts predict that ICU Medical, Inc. will post 4.11 EPS for the current fiscal year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.